You can find the annual or quarterly income statement of Ikena Oncology Inc here for insights into the performance and operational efficiency of Ikena Oncology Inc.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q2

FY2019Q4

Total revenue

--0.00

----

-100.00%0.00

-87.91%659.00K

-81.49%1.19M

424.61%2.00M

57.00%5.31M

-73.04%5.45M

70.90%6.40M

-89.24%382.00K

-2.59%3.38M

31003.08%20.22M

--3.75M

15.49%3.55M

--3.47M

-97.68%65.00K

--3.07M

--2.80M

Revenue

--0.00

----

-100.00%0.00

-87.91%659.00K

-81.49%1.19M

424.61%2.00M

57.00%5.31M

-73.04%5.45M

70.90%6.40M

-89.24%382.00K

-2.59%3.38M

31003.08%20.22M

--3.75M

15.49%3.55M

--3.47M

-97.68%65.00K

--3.07M

--2.80M

Operating expenses

129.36%26.59M

-44.25%8.44M

-40.18%9.36M

-46.49%12.07M

-43.95%11.60M

-26.12%15.14M

-24.89%15.64M

9.74%22.57M

-14.79%20.69M

-3.93%20.49M

2.37%20.83M

18.01%20.56M

32.90%24.28M

31.39%21.33M

54.21%20.35M

-33.28%17.43M

--18.27M

99.66%16.24M

--13.19M

216.70%26.12M

--8.13M

--8.25M

R&D expenses

128.19%15.56M

-59.06%4.03M

-61.48%3.71M

-67.91%4.58M

-53.47%6.82M

-35.20%9.83M

-37.98%9.64M

-8.73%14.27M

-22.26%14.65M

-2.04%15.17M

8.43%15.55M

26.75%15.64M

40.93%18.85M

36.17%15.49M

43.13%14.34M

-47.28%12.34M

--13.38M

79.57%11.37M

--10.02M

292.39%23.40M

--6.33M

--5.96M

Depreciation, depletion, and amortization

----

-5.43%87.00K

-60.27%87.00K

-70.82%89.00K

-62.81%90.00K

-61.98%92.00K

-5.19%219.00K

45.24%305.00K

13.62%242.00K

-19.33%242.00K

15.50%231.00K

28.83%210.00K

44.90%213.00K

106.90%300.00K

100.00%200.00K

63.00%163.00K

--147.00K

45.00%145.00K

--100.00K

53.85%100.00K

--100.00K

--65.00K

Other operating expenses

--26.59M

----

---100.00K

----

Operating profit

-129.36%-26.59M

44.25%-8.44M

40.18%-9.36M

44.88%-12.07M

40.55%-11.60M

18.12%-15.14M

-0.83%-15.64M

-44.95%-21.91M

-9.10%-19.50M

11.75%-18.49M

8.53%-15.52M

-641.33%-15.11M

-23.10%-17.88M

-65.14%-20.95M

-74.51%-16.96M

110.72%2.79M

---14.52M

-150.78%-12.69M

---9.72M

-378.65%-26.05M

---5.06M

---5.44M

Net non-operating interest income (expenses)

Non-operating interest income

----

324.42%730.00K

--893.00K

--576.00K

--507.00K

--172.00K

----

Gains from sale of securities

----

-32.81%1.29M

-32.92%1.42M

-30.96%1.57M

-18.09%1.77M

39.03%1.92M

--2.11M

--2.27M

--2.16M

--1.38M

----

Special income (expenses)

----

54.76%-309.00K

44.42%-1.44M

---342.00K

---812.00K

---683.00K

---2.58M

----

- Gains from disposal of fixed assets

----

---100.00K

----

Other non-operating income (expenses)

345.87%1.84M

1903.40%4.71M

11314.29%785.00K

13514.29%1.88M

20700.00%412.00K

4016.67%235.00K

-101.24%-7.00K

-111.29%-14.00K

94.74%-2.00K

87.23%-6.00K

664.86%566.00K

2380.00%124.00K

-642.86%-38.00K

-883.33%-47.00K

1750.00%74.00K

150.00%5.00K

--7.00K

-71.43%6.00K

--4.00K

-99.40%2.00K

--21.00K

--335.00K

Income before tax

-143.08%-24.85M

79.87%-2.75M

46.70%-8.59M

53.84%-9.07M

41.05%-10.22M

20.14%-13.67M

-13.36%-16.12M

-39.40%-19.65M

-0.03%-17.34M

16.48%-17.11M

15.56%-14.22M

-604.00%-14.10M

-19.45%-17.34M

-61.59%-20.49M

-73.31%-16.84M

110.74%2.80M

---14.52M

-151.71%-12.68M

---9.72M

-410.00%-26.05M

---5.04M

---5.11M

Income tax

-840.00%-74.00K

-75.81%15.00K

3.70%28.00K

132.72%53.00K

--10.00K

--62.00K

--27.00K

---162.00K

----

Income after tax

-142.12%-24.78M

79.85%-2.77M

46.62%-8.62M

53.18%-9.12M

40.99%-10.23M

19.78%-13.73M

-13.55%-16.15M

-38.25%-19.49M

-0.03%-17.34M

16.48%-17.11M

15.56%-14.22M

-604.00%-14.10M

-19.45%-17.34M

-61.59%-20.49M

-73.31%-16.84M

110.74%2.80M

---14.52M

-151.71%-12.68M

---9.72M

-410.00%-26.05M

---5.04M

---5.11M

Net income from continuous operations

-142.12%-24.78M

79.85%-2.77M

46.62%-8.62M

53.18%-9.12M

40.99%-10.23M

19.78%-13.73M

-13.55%-16.15M

-38.25%-19.49M

-0.03%-17.34M

16.48%-17.11M

15.56%-14.22M

-604.00%-14.10M

-19.45%-17.34M

-61.59%-20.49M

-73.31%-16.84M

110.74%2.80M

---14.52M

-151.71%-12.68M

---9.72M

-410.00%-26.05M

---5.04M

---5.11M

Other net gains and losses

---1.54M

----

Net income attributable to controlling interests

-150.39%-25.63M

79.85%-2.77M

46.62%-8.62M

53.18%-9.12M

40.99%-10.23M

19.78%-13.73M

-13.55%-16.15M

-38.25%-19.49M

-0.03%-17.34M

16.48%-17.11M

15.56%-14.22M

-604.00%-14.10M

-19.45%-17.34M

-61.59%-20.49M

-73.31%-16.84M

110.74%2.80M

---14.52M

-151.71%-12.68M

---9.72M

-410.00%-26.05M

---5.04M

---5.11M

Net income attributable to common shareholders

-150.39%-25.63M

79.85%-2.77M

46.62%-8.62M

53.18%-9.12M

40.99%-10.23M

19.78%-13.73M

-13.55%-16.15M

-38.25%-19.49M

-0.03%-17.34M

16.48%-17.11M

15.56%-14.22M

-604.00%-14.10M

-19.45%-17.34M

-61.59%-20.49M

-73.31%-16.84M

110.74%2.80M

---14.52M

-151.71%-12.68M

---9.72M

-410.00%-26.05M

---5.04M

---5.11M

Basic earnings per share

-1317.10%-3.01

-141.85%-0.69

46.62%-0.18

53.56%-0.19

46.88%-0.21

34.68%-0.28

14.68%-0.33

-4.71%-0.41

16.51%-0.40

23.13%-0.44

15.98%-0.39

-600.05%-0.39

-18.14%-0.48

-60.21%-0.57

-72.23%-0.47

110.32%0.08

---0.40

81.33%-0.35

---0.27

-410.01%-0.75

---1.89

---0.15

Diluted earnings per share

-1317.10%-3.01

-141.85%-0.69

46.62%-0.18

53.56%-0.19

46.88%-0.21

34.68%-0.28

14.68%-0.33

-4.71%-0.41

16.51%-0.40

23.13%-0.44

15.98%-0.39

-600.05%-0.39

-18.14%-0.48

-60.21%-0.57

-72.23%-0.47

110.32%0.08

---0.40

81.33%-0.35

---0.27

-410.01%-0.75

---1.89

---0.15

Dividend per share

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

